All articles by Anthony King – Page 12
-
FeatureThe quest to cure HIV
Although HIV–Aids can now be managed quite well with antiretroviral drugs, there is still no cure. Anthony King talks to the scientists trying to find one
-
ResearchFast freezing reveals new insights into lithium battery degradation
Cryo-STEM shows a second type of dendrites growing on lithium electrodes
-
BusinessUS approves first RNA interference drug
Alnylam’s Onpattro (patisiran) can treat a rare hereditary disease by silencing a specific gene
-
ReviewExhibition: Life at the Edges
The latest exhibition at Dublin’s Science Gallery explores life in the harshest environments, on Earth and beyond
-
BusinessInnovation in the open
Big companies are partnering with smaller ones – without trying to gobble up all their intellectual property, Anthony King finds
-
ResearchComplex metal oxides open passage to fast-charging devices
Chemists make lithium-ion battery electrodes made from niobium tungsten oxides that can rapidly intercalate large quantities of lithium
-
NewsWhat the ECJ ruling means for gene editing
The European Court of Justice has found Crispr-modified crops are subject to GMO regulations
-
ResearchAI tool could save on animal tests
Algorithm could also help unravel poisoning or environmental contamination cases
-
-
ResearchSolid electrolyte boosts liquid metal battery
Combining molten metal electrodes with a solid electrolyte may offer a cheap, scalable alternative to Li-ion batteries
-
NewsFears that US 'right to try' law could put patients at risk
Legislation will give terminally ill patients the option of taking medicines that have had little testing
-
NewsWhy antibiotic pollution is a global threat
Rising antibiotic resistance caused by pollutants needs action
-
Careers‘My video has six million views’
Biochemist Martina Hestericová on science communication and Instagram stardom
-
ResearchSurgical sensor tracks healing and then simply fades away
Exceptionally sensitive biodegradable implant can sense strain and pressure on recovering tendons
-
BusinessTakeda set to swallow Shire
Shire’s US revenue and rare diseases portfolio grab Japanese firm’s attention
-
NewsLack of ambition in Europe’s next research programme disappoints
Horizon Europe will significantly increase funding for R&D but science organisations say it’s not enough
-
NewsThe rich scientists get richer and the poor get poorer
Winning just one early career grant can mean picking up twice the funding over a decade
-
NewsWhat you need to know about neonicotinoids
The latest on the concerns raised about the pesticides’ impact on bees
-
NewsEU presidency puts lagging Bulgarian science in the spotlight
Meagre public funding and a fragmented research base means the nation is falling behind other member states
-
BusinessBattery builders get the cobalt blues
Demand for battery metals surges on the back of a global appetite for electric vehicles